| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 04/13/2004 | US6719958 Polychelants, their complexes with metal ions, their preparation and their uses |
| 04/08/2004 | WO2004029093A2 Humanized anti-granulocyte mn-3 antibody and uses thereof |
| 04/08/2004 | WO2004029080A1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 04/08/2004 | WO2004029024A2 Radiolabeled neurokinin-1 receptor antagonists |
| 04/08/2004 | WO2004028338A2 A method to demonstrate the efficacy of pharmacological stress agent |
| 04/08/2004 | WO2004009136A3 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds |
| 04/08/2004 | WO2004003016A3 Marked peptides having affinity for a phospholipid and uses |
| 04/08/2004 | WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/08/2004 | WO2003059153A3 Composition and imaging methods for pharmacokinetic and pharmacodynamic evaluation of therapeutic delivery system |
| 04/08/2004 | US20040068241 Implantable medical device |
| 04/08/2004 | US20040068020 Patient oxygenation using stabilized fluorocarbon emulsions |
| 04/08/2004 | US20040067924 Actinium-225 complexes and conjugates for targeted radiotherapy |
| 04/08/2004 | US20040067556 Growth differentiation factor-6 |
| 04/08/2004 | US20040067221 Cell delivery fluid for prevention of cell settling in delivery system |
| 04/08/2004 | US20040067200 Contrast agents in X-ray imaging, magnetic resonance imaging and radiopharmaceuticals |
| 04/08/2004 | US20040067199 Conjugates with radionuclides; radiotherapy; tumor diagnosis |
| 04/08/2004 | US20040067197 Antiproliferative; radioisotope is located internally within a dna sequence; penetrates cell membrane and is retained intracellularly |
| 04/08/2004 | US20040067196 Targeted therapeutic lipid constructs |
| 04/08/2004 | CA2500250A1 Humanized anti-granulocyte mn-3 antibody and uses thereof |
| 04/08/2004 | CA2498826A1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 04/07/2004 | EP1404867A2 Oligonucleotide transfection screening method |
| 04/07/2004 | EP1404860A2 Delivery system for nucleic acids |
| 04/07/2004 | EP1404377A2 Improved chelator conjugates |
| 04/07/2004 | EP1404376A2 Radiopharmaceutical formulations |
| 04/07/2004 | EP1404371A2 Peptide-based compounds for targeting intergin receptors |
| 04/07/2004 | EP1404353A2 Methods of using a hyaluronan receptor |
| 04/07/2004 | EP1404319A1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 04/06/2004 | US6716410 Using humanized monoclonal antibody (mab) or fragment with variable chain with oxidation specific epitopes |
| 04/01/2004 | WO2004026111A2 Flexible and/or elastic brachytherapy seed or strand |
| 04/01/2004 | WO2004004787A3 Method and device for dispensing individual doses of a radiopharmaceutical solution |
| 04/01/2004 | WO2004002401A3 Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents |
| 04/01/2004 | WO2003106659A3 Aptamer-toxin molecules and methods for using same |
| 04/01/2004 | WO2003106498A3 Ox40 (=cd134) receptor agonistic and therapeutic use |
| 04/01/2004 | WO2003106495A3 Humanized monoclonal antiboby hpam4 |
| 04/01/2004 | WO2003103644A3 Guanidino phenylalanin compounds used as urokinase inhibitors |
| 04/01/2004 | WO2003093412A3 Tumor imaging compounds |
| 04/01/2004 | WO2003092744A3 Benzothienyl analogue of somatostatin, selective for certain somatostatin receptors |
| 04/01/2004 | WO2003092743A9 Radiopharmaceutical formulations |
| 04/01/2004 | WO2002060485A9 Use of immunoregulatory antibodies in the treatment of neoplastic disorders |
| 04/01/2004 | US20040064039 Myocardial perfusion imaging method |
| 04/01/2004 | US20040063916 Bactericides; antibiotics |
| 04/01/2004 | US20040063693 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 04/01/2004 | US20040063663 Acylated cyclodextrin: guest molecule inclusion complexes |
| 04/01/2004 | US20040062714 Synthesis of 17F labeled fluoroalkanes |
| 04/01/2004 | US20040062711 Using mixture of carbohydrates, fats, proteins, carbon isotope and fiber; measuring breath sample; testing |
| 03/31/2004 | EP1402256A2 P-cadherin as a target for anti-cancer therapy |
| 03/31/2004 | EP1401818A2 Targeted multivalent macromolecules |
| 03/31/2004 | EP1401507A2 Stabilization of radionuclide-containing compositions |
| 03/31/2004 | EP1401479A2 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 03/31/2004 | EP1401467A1 Alpha-fetoprotein peptides and uses thereof |
| 03/31/2004 | EP1401430A1 Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis |
| 03/31/2004 | EP1401420A2 Perturbed membrane-binding compounds |
| 03/31/2004 | EP0783325B2 Contrast agent |
| 03/30/2004 | US6713443 Compounds which modify serotoninergic transmission, diagnostic and therapeutic applications |
| 03/30/2004 | US6713302 Growth differentiation factor-6 |
| 03/30/2004 | US6713042 Ascorbic acid analogs for metalloradiopharmaceuticals |
| 03/30/2004 | US6712846 Polymer-coated stents, processes for producing the same and their use for restenosis prevention |
| 03/25/2004 | WO2004025270A2 Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis |
| 03/25/2004 | WO2004024941A2 Biochemical methods for measuring metabolic fitness of tissues or whole organisms |
| 03/25/2004 | WO2004024878A2 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 03/25/2004 | WO2004024877A2 Human kininogen d3 domain polypeptide as an anti-angiogenic and anti-tumor agent |
| 03/25/2004 | WO2004024188A1 Preparation for controlling binging of drug to plasma protein |
| 03/25/2004 | WO2002055112A3 Polypodal chelants for metallopharmaceuticals |
| 03/25/2004 | US20040058984 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans |
| 03/25/2004 | US20040058310 Method for measuring a marker indicative of the exposure of a patient to nicotine; a kit for measuring such a marker |
| 03/25/2004 | US20040057940 Imaging and targeting tumors using sickle cells |
| 03/25/2004 | US20040057904 Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands |
| 03/25/2004 | US20040057902 For use in diagnosis and therapy |
| 03/25/2004 | US20040057901 Diagnoses and treatment of disorders using an alternative glucose pathway |
| 03/25/2004 | US20040057900 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 03/25/2004 | US20040057899 Stabilised radiopharmaceutical compositions |
| 03/25/2004 | US20040056240 Adhesive |
| 03/25/2004 | CA2498936A1 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 03/25/2004 | CA2498583A1 Biochemical methods for measuring metabolic fitness of tissues or whole organisms |
| 03/25/2004 | CA2498378A1 Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis |
| 03/24/2004 | EP1400576A1 Adhesive |
| 03/24/2004 | EP1399428A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators |
| 03/24/2004 | EP1399401A2 Solid-phase electrophilic fluorination |
| 03/24/2004 | EP1399215A2 Tissue-specific endothelial membrane proteins |
| 03/24/2004 | EP1399170A2 Chelates of metals which can be activated by neutrons and their use for the measurement of labeled specimens |
| 03/24/2004 | EP0928204B1 Measurement of liquid phase gastric emptying |
| 03/24/2004 | EP0725633B1 Capsule for detecting Helicobacter Pylori in the stomach |
| 03/24/2004 | CN1484534A Stabilised radiopharmaceutical composition |
| 03/24/2004 | CN1484526A Perturbed membrane-binding compounds |
| 03/24/2004 | CN1483782A Adhesive |
| 03/23/2004 | US6710179 Compounds with analgesic effect |
| 03/23/2004 | US6709693 Without use of cyclotron |
| 03/23/2004 | US6709652 Radioactive labeling of biotin |
| 03/23/2004 | US6709645 Synthesis of labeled metabolites |
| 03/23/2004 | US6709379 Implant with cavities containing therapeutic agents |
| 03/20/2004 | CA2404540A1 A method for measuring a marker indicative of the exposure of a patient to nicotine; a kit for measuring such a marker |
| 03/18/2004 | WO2004022106A1 Metal binding precursors for the synthesis of peptide-metal conjugates |
| 03/18/2004 | WO2004022105A2 Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support |
| 03/18/2004 | WO2004022098A1 Oxygen-enriched water, treated within a magnetic field and heavy water |
| 03/18/2004 | WO2004021996A2 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same |
| 03/18/2004 | WO2004021977A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | WO2004000204A8 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/18/2004 | WO2003099210A3 Methods of modulating tubulin deacetylase activity |
| 03/18/2004 | WO2003096978A3 Carbon-11 and fluorine-18 labeled radioligands for positron emission tomography (pet) imaging for the brain serotonin transporters |
| 03/18/2004 | WO2003076461A3 Dimeric tf antagonist comprising two factor vii polypeptides |